Anna Barbieri
Obstetrics · New York, NYNPI 1245284900
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Bayer accounts for 67.6% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $7,046, more than ten times the $594 reported in 2019. Among obstetrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $62.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$6K
- Astellas Pharma US Inc$908
- Amneal Pharmaceuticals LLC$308
- AbbVie$305
- AMAG Pharmaceuticals, Inc.$158
- Millicent US Inc$135
- plus $1K from 18 others
What the payments were for
- Consulting fees$4,97054%
- Travel & lodging$1,53117%
- Food & beverage$2,19324%
- Education$4685%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $6,193 |
| Astellas Pharma US Inc | 25 | $908 |
| Amneal Pharmaceuticals LLC | 1 | $308 |
| AbbVie(2 entities) | 38 | $305 |
| AMAG Pharmaceuticals, Inc. | 8 | $158 |
| Millicent US Inc | 8 | $135 |
| Pfizer | 8 | $127 |
| Mayne Pharma Commercial LLC | 6 | $127 |
| Avion Pharmaceuticals | 7 | $120 |
| Vertical Pharmaceuticals, LLC | 5 | $119 |
| Therapeuticsmd, Inc. | 5 | $110 |
| Exact Sciences | 5 | $106 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Myovant Sciences Inc. | 5 | $84 |
| Shield Therapeutics Inc | 3 | $51 |
| Evofem Biosciences, Inc. | 2 | $44 |
| Exeltis, USA Inc. | 2 | $42 |
| Agile Therapeutics, Inc. | 2 | $36 |
| Coopersurgical, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Renovia Inc | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
How this compares
$9,162 in reported general payments places this provider in the 95th percentile of 82 obstetrics providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IntrarosaPrasterone (Dhea) | 11 | $6,219 |
| Estradiol | 22 | $3,947 |
| Estradiol (Twice Weekly)Estradiol | 16 | $1,214 |
| ProgesteroneProgesterone, Micronized | 17 | $788 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AMAG Pharmaceuticals, Inc.Intrarosa | $158 | $6,21911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 82 obstetrics providers in New York.
Other obstetrics in New York
- Shahnoz RustamovaNew York$4K
- Suzanne LajoieNew York$3K
- Mary Cathryn EarnhardtNew York$1K
- Alison HoNew York$1K
- Sara SlatkyNew York$1K
- Lorraine ChrisomalisNew York$777
- Hope LangerNew York$772
- Gary MarkoffNew York$625
- Elena BuruianaNew York$601
- Bruno CaridiNew York$343
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.